Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of Social Anxiety Disorder

ClinicalTrials.gov ID: NCT07221578

Public ClinicalTrials.gov record NCT07221578. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 8:21 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of Acute Anxiety in Patients With Social Anxiety Disorder

Study identification

NCT ID
NCT07221578
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Vanda Pharmaceuticals
Industry
Enrollment
500 participants

Conditions and interventions

Interventions

  • VQW-765 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 21, 2025
Primary completion
Nov 30, 2026
Completion
Mar 31, 2027
Last update posted
Jul 19, 2026

2025 – 2027

United States locations

U.S. sites
30
U.S. states
15
U.S. cities
29
Facility City State ZIP Site status
Vanda Investigational Site Phoenix Arizona 85012
Vanda Investigational Site Scottsdale Arizona 85260
Vanda Investigational Site Encino California 91316
Vanda Investigational Site Mission Viejo California 92691
Vanda Investigational Site San Diego California 92123
Vanda Investigational Site San Jose California 95124
Vanda Investigational Site Walnut Creek California 94596
Vanda Investigational Site Denver Colorado 80209
Vanda Investigational Site Jacksonville Florida 32256
Vanda Investigational Site Miami Florida 33125
Vanda Investigational Site Orlando Florida 32801
Vanda Investigational Site Tampa Florida 33629
Vanda Investigational Site Atlanta Georgia 30329
Vanda Investigational Site Suwanee Georgia 30024
Vanda Investigational Site New Orleans Louisiana 70115
Vanda Investigational Site Pikesville Maryland 21208
Vanda Investigational Site Rockville Maryland 20852
Vanda Investigational Site Towson Maryland 21204
Vanda Investigational Site Saint Charles Missouri 63304
Vanda Investigational Site St Louis Missouri 63182
Vanda Investigational Site Las Vegas Nevada 89102
Vanda Investigational Site Princeton New Jersey 08540
Vanda Investigational Site Albuquerque New Mexico 87109
Vanda Investigational Site New York New York 10016
Vanda Investigational Site New York New York 10036
Vanda Investigational Site Charlotte North Carolina 28210
Vanda Investigational Site Wilmington North Carolina 28403
Vanda Investigational Site Houston Texas 77081
Vanda Investigational Site Wichita Falls Texas 76309
Vanda Investigational Site Orem Utah 84097

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07221578, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 19, 2026 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07221578 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →